Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry. LPI (LP Information)' newest research report, the “Monoclonal Mouse Antibody Industry Forecast” looks at past sales and reviews total world Monoclonal Mouse Antibody sales in 2022, providing a comprehensive analysis by region and market sector of projected Monoclonal Mouse Antibody sales for 2023 through 2029. With Monoclonal Mouse Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Mouse Antibody industry. This Insight Report provides a comprehensive analysis of the global Monoclonal Mouse Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monoclonal Mouse Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Monoclonal Mouse Antibody market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Mouse Antibody and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Mouse Antibody. The global Monoclonal Mouse Antibody market size is projected to grow from US$ 8791.1 million in 2022 to US$ 11930 million in 2029; it is expected to grow at a CAGR of 11930 from 2023 to 2029. The key players are Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals and Seattle Genetics, etc, with about 57% market shares. This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Mouse Antibody market by product type, application, key manufacturers and key regions and countries. Market Segmentation: Segmentation by type IgM IgG IgA Others Segmentation by application Therapeutic Research Diagnostic ELISA kits This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Roche Johnson & Johnson Merck Novartis AbbVie Amgen Pfizer Bayer Lilly Bristol-Myers Squibb GlaxoSmithKline Biogen AstraZeneca Sanofi Alexion Pharmaceuticals Seattle Genetics Key Questions Addressed in this Report What is the 10-year outlook for the global Monoclonal Mouse Antibody market? What factors are driving Monoclonal Mouse Antibody market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Monoclonal Mouse Antibody market opportunities vary by end market size? How does Monoclonal Mouse Antibody break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Monoclonal Mouse Antibody Annual Sales 2018-2029 2.
